Menu
Back to Journals » OncoTargets and Therapy » Volume 13
RETRACTED ARTICLE: Silencing of Long Noncoding RNA LINC00346 Inhibits the Tumorigenesis of Colorectal Cancer Through Targeting MicroRNA-148b
Authors Li T, Wang B, Zhang L, Cui M, Sun B
Received 17 December 2019
Accepted for publication 19 March 2020
Published 17 April 2020 Volume 2020:13 Pages 3247—3257
DOI https://doi.org/10.2147/OTT.S242715
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Nicola Silvestris
This paper has been retracted.
Li T, Wang B, Zhang L, Cui M, Sun B. Onco Targets Ther. 2020;13:3247—3257.
We, the Editors and Publisher of the journal Oncotargets and Therapy have retracted the following article.
Following publication, concerns were raised in September 2024 regarding Figure(s) 3A and 3B. In November 2024, the authors contacted the journal to request retraction due to missing data.
When asked for further information and an explanation for the image concerns, the authors were unable to address the concerns raised.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.